Isabelle Riviere, PhD

Secretary (2022-2025)

Dr. Riviere is director of the cell therapy and cell engineering facility at Memorial Sloan Kettering Cancer Center, where she investigates novel strategies for cell therapies and immunotherapies to increase or retarget the immune response against tumors and treat hematological disorders.


Register for the ASGCT Policy Summit

September 23-24, 2024 | Washington, D.C.

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.